CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-15 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-06-15 | Mitchell Edith P. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-06-06 | MILLER RICHARD A MD President and CEO | Purchase | +890 | $1.01 | $899 | 1,339,405 |
| 2022-06-02 | MILLER RICHARD A MD President and CEO | Purchase | +4,830 | $0.98 | $5K | 1,338,345 |
| 2022-06-02 | MILLER RICHARD A MD President and CEO | Purchase | +170 | $0.97 | $165 | 1,338,515 |
| 2022-03-31 | MILLER RICHARD A MD President and CEO | Purchase | +15,000 | $1.64 | $25K | 1,333,515 |
| 2022-03-17 | LEA LEIV Chief Financial Officer | Purchase | +13,878 | $1.65 | $23K | 99,238 |
| 2022-03-17 | MILLER RICHARD A MD President and CEO | Purchase | +5,000 | $1.59 | $8K | 1,318,515 |
| 2022-03-16 | LEA LEIV Chief Financial Officer | Purchase | +35,160 | $1.54 | $54K | 85,360 |
| 2022-03-15 | MILLER RICHARD A MD President and CEO | Purchase | +25,000 | $1.47 | $37K | 1,313,515 |
| 2021-10-01 | EcoR1 Capital, LLC 10% owner | Sale | −2,000,000 | $4.96 | $9.9M | 81,077 |
| 2021-09-30 | EcoR1 Capital, LLC 10% owner | Sale | −3,000,000 | $5.04 | $15.1M | 2,081,077 |
| 2021-09-20 | ORBIMED ADVISORS LLC Director | Sale | −1,109,644 | $6.09 | $6.8M | 6,943,654 |
| 2021-09-20 | Thompson Peter A. Director | Sale | −1,109,644 | $6.09 | $6.8M | 6,943,654 |
| 2021-09-09 | MILLER RICHARD A MD President and CEO | Grant or award · Stock Option (Right to Buy) | +320,000 | 320,000 | ||
| 2021-09-09 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2021-09-09 | Jones William Benton See Remarks | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2021-09-09 | Grais Linda Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-09-09 | Mitchell Edith P. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-09-09 | Gould Terry P Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 7 of 15 · 286 trades